Evidence map›Paper›PMID 33556324›Full record

ArticleThe Lancet. Oncology2021

Comparison of breast cancer and cervical cancer stage distributions in ten newly independent states of the former Soviet Union: a population-based study.

Anton Ryzhov, Marilys Corbex, Marion Piñeros, Anton Barchuk, Diana Andreasyan, Sayde Djanklich, Vadim Ghervas, Olga Gretsova, Dilyara Kaidarova, Konstantin Kazanjan and 6 more

Abstract readComparative Study
In one paragraph

Article in The Lancet. Oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Disparities in stage at diagnosis for liver cancer in China.Journal of the National Cancer Center · 2023
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Anton RyzhovCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France; National Cancer Registry of Ukraine, National Cancer Institute, Kyiv, Ukraine; Taras Shevchenko National University of Kyiv, Kyiv, Ukraine.
Marilys CorbexWHO Regional Office for Europe, Copenhagen, Denmark.
Marion PiñerosCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Anton BarchukTampere University, Faculty of Social Sciences/Health Sciences, Tampere, Finland; NN Petrov National Research Medical Center of Oncology, Saint Petersburg, Russia.
Diana AndreasyanNational Institute of Health, Ministry of Health, Yerevan, Armenia.
Sayde DjanklichRepublican Specialized Scientific Practical Medical Center of Oncology and Radiology, Tashkent, Uzbekistan.
Vadim GhervasInstitute of Oncology, Chisinau, Moldova.
Olga GretsovaP A Hertsen Moscow Oncology Research Center-Branch of FSBI National Medical Research Radiological Center of the Ministry of Health of the Russian Federation, Moscow, Russia.
Dilyara KaidarovaKazakh Institute of Oncology and Radiology, Almaty, Kazakhstan.
Konstantin KazanjanNational Center for Disease Control and Public Health, Tbilisi, Georgia.
Fuad MardanliNational Center of Oncology, Baku, Azerbaijan.
Yuriy MichailovichNational Cancer Registry of Ukraine, National Cancer Institute, Kyiv, Ukraine.
Elena TenScientific and Production Centre for Preventive Medicine of the Ministry of Health, Bishkek, Kyrgyzstan; International Higher School of Medicine, IUK Academic Consortium, Bishkek, Kyrgyzstan.
Alesya YaumenenkaNN Alexandrov National Cancer Centre of Belarus, Minsk, Belarus.
Freddie BrayCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France.
Ariana ZnaorCancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France. Electronic address: znaora@iarc.fr.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundScreening for breast cancer and cervical cancer in the newly independent states of the former Soviet Union is largely opportunistic, and countries in the region have among the highest cervical cancer incidence in the WHO European Region. We aimed to compare the stage-specific distributions and changes over time in breast cancer and cervical cancer incidence in the newly independent states of the former Soviet Union.

methodsWe collected breast cancer and cervical cancer incidence data from official statistics from Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Republic of Moldova, Russian Federation, Ukraine, and Uzbekistan for the years 2008-17 by tumour, node, metastasis (TNM) stage, and by age where population-based cancer registry data were available. We used log-linear regression to quantify the changes over time in age-standardised rates.

findingsDuring the period 2013-17, more than 50% of breast cancer cases across the analysed countries, and more than 75% of breast cancer cases in Belarus, Kazakhstan, and Ukraine, were registered at stages I-II. The proportion of stage I breast cancer cases was highest in the screening age group (50-69 years) compared with other ages in Moldova and the Russian registries, but was highest in those aged 15-49 years in Georgia and Ukraine. Breast cancer stage-specific incidence rates increased over time, most prominently for stage I cancers. For cervical cancer, the proportions of cancers diagnosed at a late stage (stages III and IV) were high, particularly in Moldova and Armenia (>50%). The proportion of stage I cervical cancer cases decreased with age in all countries, whereas the proportions of late stage cancers increased with age. Stage-specific incidence rates of cervical cancer generally increased over the period 2008-17.

interpretationOur results suggest modest progress in early detection of breast cancer in the newly independent states of the former Soviet Union. The high proportions of early-stage disease in the absence of mammography screening (eg, in Belarus) provide a benchmark for what is achievable with rapid diagnosis. For cervical cancer, there is a need to tackle the high burden and unfavourable stage-specific changes over time in the region. A radical shift in national policies away from opportunistic screening toward organised, population-based, quality-assured human papillomavirus vaccination and screening programmes is urgently needed.

fundingUnion for International Cancer Control, WHO Regional Office for Europe, and Ministry of Health of Ukraine.

Indexed as

AdolescentAdultAgedBreast NeoplasmsEarly Detection of CancerFemaleFollow-Up StudiesHumansIncidenceMiddle AgedNeoplasm StagingUSSRUterine Cervical NeoplasmsYoung Adult

Identifiers

PMID33556324
PMCPMC8014987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.